Abstract
Urine has been an important body fluid source for diagnostic and prognostic biomarkers of diseases for a long time. Technological advances during the last two decades have enabled a fundamental shift from the discovery of candidate protein biomarkers using single-assay platforms to highly parallel liquid chromatography tandem mass spectrometry (LC-MS/MS)-based proteomic analysis platforms. MS/MS-based approaches such as multiple reaction monitoring (MRM) are also being used increasingly for targeted protein biomarker validation. In large part due to the fact that the majority of protein in voided urine is soluble, such studies have focused on the analysis of urine supernatants, whereas the pellets were discarded after centrifugal sedimentation. Urine sediments are of particular value in the analysis of urinary tract infections (UTI). The LC-MS/MS methods now have sufficient resolving power and sensitivity to survey metaproteomes—the entirety of proteins derived from multiple organisms that interact with each other in mutualistic or antagonistic fashion. Challenges of proteomic analysis of urine include the high dynamic range of protein abundance, high levels of protein post-translational modifications, and high quantities of natural protease inhibitors. Recently, a robust and scalable workflow that can parallelize the processing of multiple urinary supernatant and sediment samples was developed and validated in our lab. This method utilizes 96-well format filter-aided sample preparation (96FASP) strategy and was shown to successfully identify large numbers of proteins from urine samples. Processing 10–50 µg total protein in single experiment, LC-MS/MS with a Q-Exactive mass spectrometer resulted in more than 1,100 distinct human protein identifications from urine supernatants, and around 400 microbial and 1,400 human protein identifications from urine sediments. The surveys are a rich data resource not only for biomarker discovery but also to interrogate mechanisms of pathogenesis in the urinary system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adachi J, Kumar C, Zhang Y, Olsen J, Mann M (2006) The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 7(9):R80. doi:10.1186/gb-2006-7-9-r80
Carty DM, Siwy J, Brennand JE, Zürbig P, Mullen W, Franke J, McCulloch JW, North RA, Chappell LC, Mischak H, Poston L, Dominiczak AF, Delles C (2011) Urinary proteomics for prediction of preeclampsia. Hypertension 57(3):561–569. doi:10.1161/hypertensionaha.110.164285
Decramer S, de Peredo AG, Breuil B, Mischak H, Monsarrat B, Bascands J-L, Schanstra JP (2008) Urine in clinical proteomics. Mol Cell Proteomics 7(10):1850–1862. doi:10.1074/mcp.R800001-MCP200
Fouts D, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh M-J, Huang S-T, Ljungberg I, Sprague B, Lucas S, Torralba M, Nelson K, Groah S (2012) Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 10(1):174. doi:10.1186/1479-5876-10-174
Kentsis A, Lin YY, Kurek K, Calicchio M, Wang YY, Monigatti F, Campagne F, Lee R, Horwitz B, Steen H, Bachur R (2010) Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Ann Emerg Med 55(1):62–70.e64. http://dx.doi.org/10.1016/j.annemergmed.2009.04.020
Kentsis A, Monigatti F, Dorff K, Campagne F, Bachur R, Steen H (2009) Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteom Clin Appl 3(9):1052–1061. doi:10.1002/prca.200900008
Kentsis A, Shulman A, Ahmed S, Brennan E, Monuteaux MC, Lee Y-H, Lipsett S, Paulo JA, Dedeoglu F, Fuhlbrigge R, Bachur R, Bradwin G, Arditi M, Sundel RP, Newburger JW, Steen H, Kim S (2013) Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Mol Med 5(2):210–220. doi:10.1002/emmm.201201494
Manza LL, Stamer SL, Ham A-JL, Codreanu SG, Liebler DC (2005) Sample preparation and digestion for proteomic analyses using spin filters. Proteomics 5(7):1742–1745. doi:10.1002/pmic.200401063
Marimuthu A, O’Meally RN, Chaerkady R, Subbannayya Y, Nanjappa V, Kumar P, Kelkar DS, Pinto SM, Sharma R, Renuse S, Goel R, Christopher R, Delanghe B, Cole RN, Harsha HC, Pandey A (2011) A comprehensive map of the human urinary proteome. J Proteome Res 10(6):2734–2743. doi:10.1021/pr2003038
Mataija-Botelho D, Murphy P, Pinto DM, MacLellan DL, Langlois C, Doucette AA (2009) A qualitative proteome investigation of the sediment portion of human urine: implications in the biomarker discovery process. PROTEOMICS—Clin Appl 3(1):95–105. doi:10.1002/prca.200800019
Nagaraj N, Mann M (2010) Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res 10(2):637–645. doi:10.1021/pr100835s
Nielubowicz GR, Mobley HLT (2010) Host-pathogen interactions in urinary tract infection. Nat Rev Urol 7(8):430–441. doi:10.1038/nrurol.2010.101
Pisitkun T, Shen R-F, Knepper MA (2004) Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 101(36):13368–13373. doi:10.1073/pnas.0403453101
Rappsilber J, Mann M, Ishihama Y (2007) Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2(8):1896–1906. doi:10.1038/nprot.2007.261
Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E (2010) The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int 107(21):361–367. doi:10.3238/arztebl.2010.0361
Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2007) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1(6):2856–2860. doi:10.1038/nprot.2006.468
Switzar L, van Angeren J, Pinkse M, Kool J, Niessen WMA (2013) A high-throughput sample preparation method for cellular proteomics using 96-well filter plates. Proteomics 13(20):2980–2983. doi:10.1002/pmic.201300080
Weichhart T, Haidinger M, Hörl WH, Säemann MD (2008) Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest 38:29–38. doi:10.1111/j.1365-2362.2008.02006.x
Wiśniewski JR, Zougman A, Mann M (2009) Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res 8(12):5674–5678. doi:10.1021/pr900748n
Yu Y, Suh M-J, Sikorski P, Kwon K, Nelson KE, Pieper R (2014) Urine sample preparation in 96-well filter plates for quantitative clinical proteomics. Anal Chem 86(11):5470–5477. doi:10.1021/ac5008317
Zimmerli LU, Schiffer E, Zürbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter KH, Mischak H, Kolch W, Delles C, Dominiczak AF (2008) Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 7(2):290–298. doi:10.1074/mcp.M700394-MCP200
Yu Y, Smith M, Pieper R (2014) A spinnable and automatable StageTip for high throughput peptide desalting and proteomics. Protocol Exchange. doi:10.1038/protex.2014.033
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Yu, Y., Pieper, R. (2015). Urine Sample Preparation in 96-well Filter Plates to Characterize Inflammatory and Infectious Diseases of the Urinary Tract. In: Gao, Y. (eds) Urine Proteomics in Kidney Disease Biomarker Discovery. Advances in Experimental Medicine and Biology, vol 845. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9523-4_8
Download citation
DOI: https://doi.org/10.1007/978-94-017-9523-4_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9522-7
Online ISBN: 978-94-017-9523-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)